Market News & Trends
Germany’s Pharmaceutical Market Value Will Crawl to $65 Billion
While Germany is the leading pharmaceutical market in Europe, valued at $58.6 billion in 2014, the sector will expand at a modest Compound Annual Growth…
The $700-Billion Connected Life Market That Will Drive Change & Growth
We are living a connected life in a connected world. Our smartphone is our gateway to the world, and very soon, we will be able…
From Volume to Value
By: Alan Shortall, Unilife Chairman & CEO As healthcare markets continue to shift to a model based on value-based outcomes, Bluetooth-enabled smart medical technologies…
New Mechanism for Engineering Genetic Traits Governed by Multiple Genes Paves Way for Various Advances
When it comes to gene expression, scientists have so far studied one single gene at a time. A new approach developed by Harvard geneticist George…
US Asthma Treatment Market Value to Hit $14 Billion
The US treatment market for asthma will rise in value from $11.7 billion in 2013 to an estimated $14 billion by 2020, representing a Compound…
AgeneBio Announces Phase II Clinical Trial Results
AgeneBio recently announced the publication of complete Phase II clinical trial results in NeuroImage: Clinical for its lead product candidate. The results show that AGB101…
Allergen Research Corporation Completes $80-Million Financing to Advance Drug Development Portfolio
Allergen Research Corporation (ARC) recently announced the completion of an $80- million Series B financing. Foresite Capital led the round, with participation from existing investor…
PhaseBio Raises $40 Million, Led By AstraZeneca
PhaseBio Pharmaceuticals, Inc., a leading company in the field of biopolymer-based drugs and focused on developing treatments for metabolic and specialty cardiopulmonary disorders, recently announced…
Charleston Laboratories & Daiichi Sankyo Announce Completion of Pharmacokinetics Study
Charleston Laboratories, Inc. and its co-development and co-commercialization partner, Daiichi Sankyo, Inc., recently announced the completion of a pharmacokinetics study on CL-108, Charleston Laboratories' lead…
Kura Oncology Announces License Agreement; Closes $60 Million
Kura Oncology, Inc. recently announced it has entered into an agreement with Janssen Pharmaceutica NV for an exclusive license to develop and commercialize tipifarnib in…
Impax Laboratories Completes Major Acquisitions
Impax Laboratories, Inc. recently announced it has completed its acquisition of Tower Holdings, Inc. (including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC), and Lineage…
Xcelience to Expand Operations, Will Create 100 New Jobs, Capital Investment of More Than $9 Million
TAMPA, Fla. – March 13, 2014 - Today, Governor Rick Scott announced the expansion of Xcelience, an international contract development and manufacturing organization (CDMO) servicing…
Opportunities Galore in Biosimilars Industry
BCC Research reveals in its new report on biosimilars, the development of biotherapeutics through the use of advanced technology has facilitated the management of disease…
Stents Market to Reach More Than $10.6 Billion in 2019
BCC Research reveals in its new report on stents there has recently been several innovations and developments expected to influence the market, particularly with bioabsorbable…
Combination Product Technology to Reach $31 Billion; Sector Attracting Massive Developmental Companies
BCC Research reveals in its new report on drug-device combination products, developments in cell-based therapeutics, progenitor cell exploitation, growth factor delivery, and advanced formulation strategies…
Patheon Adds Complex Solubility Expertise With Acquisition of Agere
Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has reached a definitive agreement to acquire…
ModiQuest Research & Cellectis to Collaborate on Antibody Generation for Potential CAR Development
ModiQuest Research BV, the Dutch antibody services company, recently announced that it has entered into a collaboration with Cellectis aimed at the generation of novel…
Macrolide Pharmaceuticals Launches With $22-Million Financing
Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis Venture Fund,…
PlasmaTech Biopharmaceuticals Announces Initiation of Enrollment of MuGard Trial
PlasmaTech Biopharmaceuticals, Inc. recently announced that enrollment has begun in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center that is evaluating MuGard in the…
AbbVie Acquires Pharmacyclics to Help Secure Future Cash Flows as Humira Biosimilars Loom
“AbbVie’s acquisition of Pharmacyclics (PCYC), valued at $21 billion, will help the company alleviate its dependency on Humira, which accounted for 62% of its total…
